Product Overview: Clomid 50 Pharmaqo
Clomid 50 Pharmaqo is a pharmaceutical-grade selective estrogen receptor modulator formulated for in-vitro post-cycle therapy research applications. This compound provides researchers with standardised clomiphene citrate to investigate hormonal recovery mechanisms and selective estrogen receptor antagonism. Our Stroid UK Shop ensures consistent compound availability for ongoing research protocols examining endocrine system modulation.
Scientific Investigation Parameters
Researchers utilise this compound to examine hypothalamic-pituitary-gonadal axis recovery following androgenic suppression. The selective receptor antagonism properties enable detailed analysis of gonadotropin release mechanisms in controlled laboratory conditions. Studies investigating clomiphene citrate protocols demonstrate tissue-selective estrogen receptor modulation. This research compound facilitates examination of luteinising hormone and follicle-stimulating hormone production pathways. Comparative studies alongside selective androgen receptor modulators reveal comprehensive endocrine interaction profiles. Advanced research protocols examine receptor binding affinity and downstream signalling cascades in cellular models. Laboratory investigations compare efficacy against other selective modulators including peptide-based compounds for comprehensive hormonal research frameworks.
Laboratory Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Clomiphene Citrate |
| Concentration | 50mg per tablet |
| Purity | Pharmaceutical Grade |
| Manufacturer | Pharmaqo Labs |
| CAS Number | 50-41-9 |
| Molecular Formula | C₂₆H₂₈ClNO·C₆H₈O₇ |
| Storage | Room temperature, dry |
Research Compliance Framework
This product is manufactured exclusively for in-vitro research applications and laboratory analysis. Not intended for human consumption, clinical application, or therapeutic intervention. Researchers must maintain appropriate laboratory protocols and safety procedures when handling this compound. All investigations should comply with institutional research guidelines and regulatory frameworks governing experimental compound usage.
